age as a biomarker for targetable mutations in advanced breast cancer
Published 3 weeks ago • 13 plays • Length 1:18Download video MP4
Download video MP3
Similar videos
-
3:22
pten protein and gene expression as a biomarker in breast cancer
-
1:14
molecular characterization of breast cancer across age groups in the aurora program
-
2:28
important biomarkers in luminal type breast cancer and dcis
-
0:42
what future does ctdna have as a biomarker in breast cancer?
-
1:47
ccng1 as a biomarker for drg-101 gene therapy in cancer
-
15:45
biomarkers 101 | breast cancer in young adults with ysc
-
53:00
genomic biomarker for predicting response in early breast cancer patients
-
1:02:45
biomarkers in breast cancer: current practice, opportunities and unmet needs
-
1:39
dr. hurvitz on the lack of predictive biomarkers in her2 breast cancer
-
1:14
the importance of a biomarker-directed approach in triple-negative breast cancer
-
2:39
early genetic and biomarker testing led to targeted therapies
-
6:09
ki-67 index after neoadjuvant et as a prognostic biomarker for hr /her2- early breast cancer
-
6:27
brca across tumour types
-
2:21
profiling of brca mutations in colorectal cancer
-
15:26
biomarker testing & metastatic breast cancer
-
1:00
the role of biomarkers in patients with breast cancer
-
1:02:45
biomarkers in breast cancer: current practice, opportunities and unmet needs
-
1:52
tils as a prognostic biomarker for treatment de-escalation in her2-positive breast cancer
-
11:23
introduction: biomarkers in breast cancer